Y07801N Recombinant Human TGF-β2 Product Brochure

Cat#:Y07801N

Name:Y07801N Recombinant Human TGF-β2

Species:Human

Specification:10μg/50μg/1mg

Purity:≥95%

Endotoxin: ≤10EU/mg

Expression System:CHO

Online Consultation

Related applications

Product Details
Data
Related Products

Product Details

Cat. No.

Y07801N

Purity

≥95%, by SDS-PAGE (under reducing (R) & Non-reducing conditions, visualized by Coomassie staining)

Endotoxin

≤10 EU/mg by the LAL method

Bioactivity

Measured in a cell inhibition assay using TF-1 cells at IL4 presence. The ED₅₀ for this effect is ≤0.3ng/mL.

Accession

P61812

Alternative Names

Transforming growth factor beta-2; TGFB2; Polyergin; G-TSF; Glioblastoma-derived T-cell suppressor factor; Cetermin; BSC-1 cell growth inhibitor; TGF-beta-2

Species

Human

Expression System

CHO

Target Protein Sequence

ALDAAYCFRNVQDNCCLRPLYIDFKRDLGWKWIHEPKGYNANFCAGACPYLWSSDTQHSRVLSLYNTINPEASASPCCVSQDLEPLTILYYIGKTPKIEQLSNMIVKSCKCS

Mol. Weight

12.7 kDa

Expression Region

Ala 303-Ser 414

Tag Info

Tag free

Formulation

Lyophilized

Buffer

0.085% TFA, 30% ACN, 5% mannitol, pH 2.5

Size

10μg/vail 50μg/vail 1mg/vail

Lead Time

Products are in stock,but custom products may require further consultation

Reconstitution

It is recommended to redissolve in 4mM HCL.

Shipping

The product is shipped with blue ice

Storage & Stability

36 months at 2°C to 8°C in lyophilized state

6 months at -20°C to -80°C under sterile conditions after reconstitution

7-10 days at 2°C to 8°C under sterile conditions after reconstitution

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

Data

SDS-PAGE

Recombinant Human TGF-β2 (Cat. No. Y07801N) SDS-PAGE under reducing (R) & Non-reducing conditions. The gel was stained with Y07801N SDS-PAGE.

Bioactivity

‍

Measured in a cell inhibition assay using TF-1 cells at IL4 presence. The ED₅₀ for this effect is ≤0.3ng/mL.